Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Italy leads the way on child genetic disease diagnosis

 April 21, 2026

Pharmaphorum

A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.

Policy / PricingRare DiseaseRead full story

Post navigation

Asahi Kasei acquires German company Aicuris →
← Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com